Indications and uses
• For flushing the eye to remove loose foreign material or air pollutants (smog or pollen)
• For flushing the eye to remove loose foreign material or air pollutants (smog or pollen)
• Flush the affected eye as needed, controlling the rate of flow of solution by pressure on the bottle
Purified water 98.577% w/v
eye wash
For external use only
Do not use
When using this product
Stop use and ask a doctor if
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
disodium EDTA, polyhexanide (PHMB), sodium chloride, sodium hydroxide, sodium phosphate dibasic, sodium phosphate monobasic
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1053173 | water 98.6 % Ophthalmic Irrigation Solution | PSN | 1 |
| 1053173 | water 986 MG/ML Ophthalmic Irrigation Solution | SCD | 1 |
| 1053173 | water 98.577 % Ophthalmic Irrigation Solution | SY | 1 |
| 1053173 | water 98.6 % Ophthalmic Irrigation Solution | SY | 1 |
| 1053173 | water 98.6 ML per 100 ML Ophthalmic Irrigation Solution | SY | 1 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 42961-090-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-337e-60a7-e053-dbdaa90a05bd | Drug Facts |
| 42961-091-02 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-337e-60a7-e053-dbdaa90a05bd | Drug Facts |
| 42961-092-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-337e-60a7-e053-dbdaa90a05bd | Drug Facts |
| 42961-093-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-337e-60a7-e053-dbdaa90a05bd | Drug Facts |
| 42961-094-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-337e-60a7-e053-dbdaa90a05bd | Drug Facts |
| 42961-094-02 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-337e-60a7-e053-dbdaa90a05bd | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42961-090-01 | fad first aid direct Eyewash | 15 mL in 1 VIAL, SINGLE-USE | SOLUTION | 15 | 1 | |
| 42961-091-01 | Xpect First aid Buffered Eyewash | 15 mL in 1 VIAL, SINGLE-USE | SOLUTION | 15 | 1 | |
| 42961-091-02 | Xpect First aid Buffered Eyewash | 5 in 1 BOX | SOLUTION | 5 | 1 | |
| 42961-092-01 | Eyewash Flushing Solution | 118 mL in 1 BOTTLE, PLASTIC | SOLUTION | 118 | 1 | |
| 42961-093-01 | Xpect First aid Buffered Eye and Skin | 118 mL in 1 BOTTLE, PLASTIC | SOLUTION | 118 | 1 | |
| 42961-094-01 | fad first aid direct Buffered Eye and Skin | 236 mL in 1 BOTTLE, PLASTIC | SOLUTION | 236 | 1 | |
| 42961-094-02 | fad first aid direct Buffered Eye and Skin | 474 mL in 1 BOTTLE, PLASTIC | SOLUTION | 474 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 42961-090 | FAD FIRST AID DIRECT EYEWASH (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYEWASH (PURIFIED WATER) SOLUTION EYEWASH FLUSHING SOLUTION (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION FAD FIRST AID DIRECT BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION [CINTAS CORPORATION] | 1 | Legacy NDC, 1 package rows | 20140729_d38a90ce-4733-4abb-a2ac-8176273a6515.zip |
| 42961-091 | FAD FIRST AID DIRECT EYEWASH (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYEWASH (PURIFIED WATER) SOLUTION EYEWASH FLUSHING SOLUTION (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION FAD FIRST AID DIRECT BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION [CINTAS CORPORATION] | 1 | Legacy NDC, 2 package rows | 20140729_d38a90ce-4733-4abb-a2ac-8176273a6515.zip |
| 42961-092 | FAD FIRST AID DIRECT EYEWASH (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYEWASH (PURIFIED WATER) SOLUTION EYEWASH FLUSHING SOLUTION (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION FAD FIRST AID DIRECT BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION [CINTAS CORPORATION] | 1 | Legacy NDC, 1 package rows | 20140729_d38a90ce-4733-4abb-a2ac-8176273a6515.zip |
| 42961-093 | FAD FIRST AID DIRECT EYEWASH (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYEWASH (PURIFIED WATER) SOLUTION EYEWASH FLUSHING SOLUTION (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION FAD FIRST AID DIRECT BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION [CINTAS CORPORATION] | 1 | Legacy NDC, 1 package rows | 20140729_d38a90ce-4733-4abb-a2ac-8176273a6515.zip |
| 42961-094 | FAD FIRST AID DIRECT EYEWASH (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYEWASH (PURIFIED WATER) SOLUTION EYEWASH FLUSHING SOLUTION (PURIFIED WATER) SOLUTION XPECT FIRST AID BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION FAD FIRST AID DIRECT BUFFERED EYE AND SKIN (PURIFIED WATER) SOLUTION [CINTAS CORPORATION] | 1 | Legacy NDC, 2 package rows | 20140729_d38a90ce-4733-4abb-a2ac-8176273a6515.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| WATER | ACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| WATER | ACTIVE MOIETY | 059QF0KO0R | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| POLIHEXANIDE | INACTIVE INGREDIENT | 322U039GMF | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 1 | |
| SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | INACTIVE INGREDIENT | E1W4N241FO | 1 | |
| SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | INACTIVE INGREDIENT | 5QWK665956 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 42961-090 | 42961-090-01 |
| 42961-091 | 42961-091-01, 42961-091-02 |
| 42961-092 | 42961-092-01 |
| 42961-093 | 42961-093-01 |
| 42961-094 | 42961-094-01, 42961-094-02 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, FILM COATED / ORAL | 8 mg | ||
| SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | 5QWK665956 | INJECTION, SOLUTION / SUBCUTANEOUS | 0.3 %w/v | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / OPHTHALMIC | 13 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / PERIODONTAL | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / AURICULAR (OTIC) | 18 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRA-ARTICULAR | 26 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / OPHTHALMIC | 4 mg | ||
| SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | E1W4N241FO | INJECTION, SOLUTION / INTRAVENOUS | 39 mg | ||
| SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | 5QWK665956 | SUSPENSION / ORAL | 140 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / NASAL | NA | ||
| SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | 5QWK665956 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 1.3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER / RESPIRATORY (INHALATION) | NA | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVITREAL | 10 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 7.01 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAVITREAL | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | NA | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 5.4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / ORAL | 4 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, COATED PELLETS / ORAL | 0.01 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | DROPS / OPHTHALMIC | NA | ||
| SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE | E1W4N241FO | SOLUTION/ DROPS / OPHTHALMIC | 5 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SUBCUTANEOUS | 6 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LOTION / TOPICAL | 21 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | ELIXIR / ORAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER / INTRAVENOUS | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INHALANT / RESPIRATORY (INHALATION) | 3 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CREAM / TOPICAL | 69 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL | 1.35 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION/ DROPS / OPHTHALMIC | 0.13 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / AURICULAR (OTIC) | 0.05 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE / ORAL | 60 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION/ DROPS / AURICULAR (OTIC) | 3 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ORAL | 98 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER / RESPIRATORY (INHALATION) | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRALESIONAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GRANULE, FOR SUSPENSION / ORAL | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRACARDIAC | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRALESIONAL | 13 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | GEL / VAGINAL | 10 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRADERMAL | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / INTRAVENOUS | 0.9 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SUBCUTANEOUS | 31.45 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / INTRAVENOUS | 0.05 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRASYNOVIAL | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SPRAY, METERED / NASAL | 36 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAOCULAR | 320 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / TOPICAL | 0.05 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PERIDURAL | 8.07 mg | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / INTRAPERITONEAL | 0.54 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / SOFT TISSUE | ADJ PH | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | PASTE / DENTAL | 0.6 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | DROPS / OPHTHALMIC | 0.08 %w/w | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / INTRAVENOUS | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / TOPICAL | 0.32 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d38a90ce-4733-4abb-a2ac-8176273a6515 | d38a90ce-4733-4abb-a2ac-8176273a6515 | 2014-07-15 | Warnings | d38a90ce-4733-4abb-a2ac-8176273a6515 d38a90ce-4733-4abb-a2ac-8176273a6515 |
Adverse event summaries are temporarily unavailable. Other product information remains available.